Original article
Online First™Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study
Runmei Li, Changli Wang, Liang Liu, Chunjuan Du and Shui Cao, et al.
Online First™, 13 May 2012
Original Article
Online First™Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment
Sebastian Dempe, Muriel Lavie, Sofie Struyf, Rauf Bhat and Hannelien Verbeke, et al.
Online First™, 11 May 2012
Opinion Paper
Online First™Open AccessReflections upon human cancer immune responsiveness to T cell-based therapy
Ena Wang, Sara Tomei and Francesco M. Marincola
Online First™, 11 May 2012
Symposium-in-writing paper
Online First™Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization
Mariana Castells, Maria del Carmen Sancho-Serra and Maria Simarro
Online First™, 11 May 2012
Original Article
Online First™Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination
Steven De Vleeschouwer, Hilko Ardon, Frank Van Calenbergh, Raf Sciot and Guido Wilms, et al.
Online First™, 8 May 2012
Original Article
Online First™Open AccessSurvivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
Jürgen C. Becker, Mads H. Andersen, Valeska Hofmeister-Müller, Marion Wobser and Lidia Frey, et al.
Online First™, 8 May 2012
Short Communication
Online First™Uterine leiomyosarcoma diffusely express disialoganglioside GD2 and bind the therapeutic immunocytokine 14.18-IL2: implications for immunotherapy
Angela J. Ziebarth, Mildred A. Felder, Josephine Harter and Joseph P. Connor
Online First™, 6 May 2012
Original Article
Online First™Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes
Ines Moeller, Giulio C. Spagnoli, Jürgen Finke, Hendrik Veelken and Leonora Houet
Online First™, 6 May 2012
Original Article
Online First™Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients
Andrés Tittarelli, Fermín E. González, Cristián Pereda, Gabriela Mora and Leonel Muñoz, et al.
Online First™, 3 May 2012
Focussed Research Review
Online First™Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC)
Suzanne Ostrand-Rosenberg, Pratima Sinha, Olesya Chornoguz and Christopher Ecker
Online First™, 1 May 2012